Finding 957126 (2023-007)

Significant Deficiency
Requirement
P
Questioned Costs
-
Year
2023
Accepted
2024-03-15

AI Summary

  • Core Issue: Significant deficiencies in internal controls over payroll processes led to issues with timesheet submission and approval.
  • Impacted Requirements: Non-compliance with federal regulations on internal controls, resulting in potential errors and unallowable costs.
  • Recommended Follow-Up: Implement robust internal controls for timesheet tracking, submission, and approval to ensure compliance and timely employee compensation.

Finding Text

2023-007 – Internal Controls Over Compliance Federal Program: Refugee and Entrant Assistance Program Federal Agency: U.S. Department of Health and Human Services Assistance Listing Number: 93.566 Repeat of Prior Finding: No Type of Finding: Significant Deficiency in Internal Controls Over Compliance Criteria In accordance Title 2 of U.S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance), Subpart D § 200.303 states the following regarding internal control: “The non-Federal entity must: (a) Establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. These internal controls should be in compliance with guidance in ‘Standards for Internal Control in the Federal Government’ issued by the Comptroller General of the United States or the “Internal Control Integrated Framework,” issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). (b) Comply with the U.S. Constitution, Federal statutes, regulations, and the terms and conditions of the Federal awards. (c) Evaluate and monitor the non-Federal entity's compliance with statutes, regulations and the terms and conditions of Federal awards. (d) Take prompt action when instances of noncompliance are identified including noncompliance identified in audit findings (e) Take reasonable measures to safeguard protected personally identifiable information and other information the Federal awarding agency or pass-through entity designates as sensitive or the non-Federal entity considers sensitive consistent with applicable Federal, State, local, and tribal laws regarding privacy and responsibility over confidentiality.” Condition and Context During our testing of payroll transactions, it was determined that certain timesheets selected did not have sufficient evidence that the timesheet was submitted by the employee and approved by the supervisor or management. Additionally, certain timesheets were not submitted timely resulting in late payment of employee compensation. Further, there were instances where dates on timesheets did not coincide with the Organization’s stated pay period. Lastly, overtime pay for hourly workers should have been remitted but was not. Condition and Context During our testing of payroll transactions, it was determined that certain timesheets selected did not have sufficient evidence that the timesheet was submitted by the employee and approved by the supervisor or management. Additionally, certain timesheets were not submitted timely resulting in late payment of employee compensation. Further, there were instances where dates on timesheets did not coincide with the Organization’s stated pay period. Lastly, overtime pay for hourly workers should have been remitted but was not. Cause The Organization did not maintain proper controls over payroll transactions sufficient to ensure that all timesheets were properly submitted and approved in a timely manner. Additionally, there were not controls in place to ensure that overtime pay was properly calculated and distributed. Effect or Potential Effect Failure to establish internal controls sufficient to ensure proper and timely submission and approval of employee timesheets could potentially result in errors and unallowable costs being charged to the grants and/or untimely payment of compensation to employees. Additionally, failure to establish controls around employee time reporting could result in employees not receiving overtime pay to which they were entitled. Questioned Costs None noted. Recommendations We recommend the Organization establish internal controls and policies to ensure that timesheets are tracked properly, submitted by employees and verified and approved by a supervisor, with adequate documented support of the approvals. Additionally, we recommend that the Organization establishes controls that dates on timesheet align with the Organization’s stated pay period. Views of Responsible Officials and Planned Corrective Actions Management agrees with the finding and recommendations. See the attached corrective action plan.

Categories

Allowable Costs / Cost Principles Reporting

Other Findings in this Audit

  • 380648 2023-005
    Material Weakness
  • 380649 2023-005
    Material Weakness
  • 380650 2023-005
    Material Weakness
  • 380651 2023-005
    Material Weakness
  • 380652 2023-005
    Material Weakness
  • 380653 2023-005
    Material Weakness
  • 380654 2023-005
    Material Weakness
  • 380655 2023-005
    Material Weakness
  • 380656 2023-005
    Material Weakness
  • 380657 2023-005
    Material Weakness
  • 380658 2023-005
    Material Weakness
  • 380659 2023-005
    Material Weakness
  • 380660 2023-005
    Material Weakness
  • 380661 2023-005
    Material Weakness
  • 380662 2023-005
    Material Weakness
  • 380663 2023-005
    Material Weakness
  • 380664 2023-005
    Material Weakness
  • 380665 2023-005
    Material Weakness
  • 380666 2023-006
    Material Weakness Repeat
  • 380667 2023-006
    Material Weakness Repeat
  • 380668 2023-006
    Material Weakness Repeat
  • 380669 2023-006
    Material Weakness Repeat
  • 380670 2023-006
    Material Weakness Repeat
  • 380671 2023-006
    Material Weakness Repeat
  • 380672 2023-006
    Material Weakness Repeat
  • 380673 2023-006
    Material Weakness Repeat
  • 380674 2023-006
    Material Weakness Repeat
  • 380675 2023-006
    Material Weakness Repeat
  • 380676 2023-006
    Material Weakness Repeat
  • 380677 2023-006
    Material Weakness Repeat
  • 380678 2023-006
    Material Weakness Repeat
  • 380679 2023-006
    Material Weakness Repeat
  • 380680 2023-006
    Material Weakness Repeat
  • 380681 2023-006
    Material Weakness Repeat
  • 380682 2023-006
    Material Weakness Repeat
  • 380683 2023-006
    Material Weakness Repeat
  • 380684 2023-007
    Significant Deficiency
  • 380685 2023-007
    Significant Deficiency
  • 380686 2023-007
    Significant Deficiency
  • 380687 2023-007
    Significant Deficiency
  • 380688 2023-007
    Significant Deficiency
  • 380689 2023-007
    Significant Deficiency
  • 380690 2023-007
    Significant Deficiency
  • 380691 2023-007
    Significant Deficiency
  • 380692 2023-007
    Significant Deficiency
  • 380693 2023-007
    Significant Deficiency
  • 380694 2023-007
    Significant Deficiency
  • 380695 2023-007
    Significant Deficiency
  • 380696 2023-007
    Significant Deficiency
  • 380697 2023-007
    Significant Deficiency
  • 380698 2023-007
    Significant Deficiency
  • 380699 2023-007
    Significant Deficiency
  • 380700 2023-007
    Significant Deficiency
  • 380701 2023-007
    Significant Deficiency
  • 380702 2023-008
    Significant Deficiency
  • 380703 2023-008
    Significant Deficiency
  • 380704 2023-008
    Significant Deficiency
  • 380705 2023-008
    Significant Deficiency
  • 380706 2023-008
    Significant Deficiency
  • 380707 2023-008
    Significant Deficiency
  • 380708 2023-008
    Significant Deficiency
  • 380709 2023-008
    Significant Deficiency
  • 380710 2023-008
    Significant Deficiency
  • 380711 2023-008
    Significant Deficiency
  • 380712 2023-008
    Significant Deficiency
  • 380713 2023-008
    Significant Deficiency
  • 380714 2023-008
    Significant Deficiency
  • 380715 2023-008
    Significant Deficiency
  • 380716 2023-008
    Significant Deficiency
  • 380717 2023-008
    Significant Deficiency
  • 380718 2023-008
    Significant Deficiency
  • 380719 2023-008
    Significant Deficiency
  • 957090 2023-005
    Material Weakness
  • 957091 2023-005
    Material Weakness
  • 957092 2023-005
    Material Weakness
  • 957093 2023-005
    Material Weakness
  • 957094 2023-005
    Material Weakness
  • 957095 2023-005
    Material Weakness
  • 957096 2023-005
    Material Weakness
  • 957097 2023-005
    Material Weakness
  • 957098 2023-005
    Material Weakness
  • 957099 2023-005
    Material Weakness
  • 957100 2023-005
    Material Weakness
  • 957101 2023-005
    Material Weakness
  • 957102 2023-005
    Material Weakness
  • 957103 2023-005
    Material Weakness
  • 957104 2023-005
    Material Weakness
  • 957105 2023-005
    Material Weakness
  • 957106 2023-005
    Material Weakness
  • 957107 2023-005
    Material Weakness
  • 957108 2023-006
    Material Weakness Repeat
  • 957109 2023-006
    Material Weakness Repeat
  • 957110 2023-006
    Material Weakness Repeat
  • 957111 2023-006
    Material Weakness Repeat
  • 957112 2023-006
    Material Weakness Repeat
  • 957113 2023-006
    Material Weakness Repeat
  • 957114 2023-006
    Material Weakness Repeat
  • 957115 2023-006
    Material Weakness Repeat
  • 957116 2023-006
    Material Weakness Repeat
  • 957117 2023-006
    Material Weakness Repeat
  • 957118 2023-006
    Material Weakness Repeat
  • 957119 2023-006
    Material Weakness Repeat
  • 957120 2023-006
    Material Weakness Repeat
  • 957121 2023-006
    Material Weakness Repeat
  • 957122 2023-006
    Material Weakness Repeat
  • 957123 2023-006
    Material Weakness Repeat
  • 957124 2023-006
    Material Weakness Repeat
  • 957125 2023-006
    Material Weakness Repeat
  • 957127 2023-007
    Significant Deficiency
  • 957128 2023-007
    Significant Deficiency
  • 957129 2023-007
    Significant Deficiency
  • 957130 2023-007
    Significant Deficiency
  • 957131 2023-007
    Significant Deficiency
  • 957132 2023-007
    Significant Deficiency
  • 957133 2023-007
    Significant Deficiency
  • 957134 2023-007
    Significant Deficiency
  • 957135 2023-007
    Significant Deficiency
  • 957136 2023-007
    Significant Deficiency
  • 957137 2023-007
    Significant Deficiency
  • 957138 2023-007
    Significant Deficiency
  • 957139 2023-007
    Significant Deficiency
  • 957140 2023-007
    Significant Deficiency
  • 957141 2023-007
    Significant Deficiency
  • 957142 2023-007
    Significant Deficiency
  • 957143 2023-007
    Significant Deficiency
  • 957144 2023-008
    Significant Deficiency
  • 957145 2023-008
    Significant Deficiency
  • 957146 2023-008
    Significant Deficiency
  • 957147 2023-008
    Significant Deficiency
  • 957148 2023-008
    Significant Deficiency
  • 957149 2023-008
    Significant Deficiency
  • 957150 2023-008
    Significant Deficiency
  • 957151 2023-008
    Significant Deficiency
  • 957152 2023-008
    Significant Deficiency
  • 957153 2023-008
    Significant Deficiency
  • 957154 2023-008
    Significant Deficiency
  • 957155 2023-008
    Significant Deficiency
  • 957156 2023-008
    Significant Deficiency
  • 957157 2023-008
    Significant Deficiency
  • 957158 2023-008
    Significant Deficiency
  • 957159 2023-008
    Significant Deficiency
  • 957160 2023-008
    Significant Deficiency
  • 957161 2023-008
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
97.010 Citizenship Education and Training $158,085
14.228 Community Development Block Grants/state's Program and Non-Entitlement Grants in Hawaii $154,642
93.268 Immunization Cooperative Agreements $46,266
93.566 Refugee and Entrant Assistance_state Administered Programs $10,824
21.027 Coronavirus State and Local Fiscal Recovery Funds $6,428
14.218 Community Development Block Grants/entitlement Grants $4,300